Elevation Oncology Announces Appointment of Darcy Mootz, Ph.D., to its Board of Directors

January 22, 2024

https://www.prnewswire.com/news-releases/elevation-oncology-announces-appointment-of-darcy-mootz-phd-to-its-board-of-directors-302039779.html

BOSTON, Jan. 22, 2024 /PRNewswire/ — Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs, today announced the appointment of Darcy Mootz, Ph.D., to its Board of Directors. Dr. Mootz is an experienced life sciences executive, who brings expertise across corporate strategy, corporate development, finance, and operations to Elevation Oncology’s Board of Directors.

Read more at prnewswire.com

Related news for (ELEV)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.